EUVIMEDEUVIMED entdecken
Crossref

Increased plasma levels of monocyte chemoattractant protein‐1 in patients with hepatitis B virus pre‐S2 gene deletion mutation predict a higher risk of hepatocellular carcinoma recurrence after curative surgical resection

Long-Bin Jeng iD, Tsai-Chung Li, John Wang, Chiao-Fang Teng iD

Cancer · 2023

DOI: 10.1002/cncr.34815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2023. Verfasst von Long-Bin Jeng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hepatitis B, Hepatitis B, Chronic, Liver Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite resection surgery as a curative therapy for hepatocellular carcinoma (HCC), the high rate of postoperative HCC recurrence remains a big challenge for patient survival. Chronic hepatitis B virus (HBV) infection is the most important risk factor for HCC. Deletion mutation in the HBV pre‐S2 gene leads to expression of an essential viral oncoprotein called pre‐S2 mutant and represents an independent prognostic biomarker for HCC recurrence after curative surgical resection. Additionally, cytokines are multifunctional secreted proteins and implicated in all stages of HBV‐related HCC tumorigenesis.

Methods

This study aimed to identify the cytokines whose plasma levels were associated with pre‐S2 gene deletion mutation and HCC recurrence and evaluate their potential to be combined with pre‐S2 gene deletion mutation in predicting HCC recurrence.

Results

Among a panel of 27 cytokines examined, plasma levels of monocyte chemoattractant protein‐1 (MCP‐1) were significantly upregulated in patients with pre‐S2 gene deletion mutation or HCC recurrence. MCP‐1 was validated as an independent prognostic biomarker for HCC recurrence. Moreover, patients with both the presence of pre‐S2 gene deletion mutation and high levels of MCP‐1 displayed a higher risk of HCC recurrence than patients with either one or none of these two biomarkers. The combination of pre‐S2 gene deletion mutation and MCP‐1 levels exhibited a better prognostic performance for HCC recurrence than each biomarker alone.

Conclusions

This study discovered that MCP‐1 levels had a significance to be as a combination biomarker with pre‐S2 gene deletion mutation providing an improved performance in predicting HCC recurrence after curative surgical resection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularHepatitis BHepatitis B, ChronicLiver NeoplasmsHumansChemokine CCL2Gene DeletionHepatitis B Surface AntigensHepatitis B virusMutation

Stichwörter der Autor:innen

hepatitis B virushepatocellular carcinomamonocyte chemoattractant protein-1pre-S2 gene deletion mutationrecurrence

Substanzen

Chemokine CCL2Hepatitis B Surface AntigensCCL2 protein, human

Autor:innen und Institutionen

  • Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan.
  • Department of Surgery, China Medical University Hospital, Taichung, Taiwan.
  • Cell Therapy Center, China Medical University Hospital, Taichung, Taiwan.
  • Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan.
  • Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung, Taiwan.
  • Department of Pathology, China Medical University Hospital, Taichung, Taiwan.

ORCID-Profile: Long-Bin Jeng, Chiao-Fang Teng

Zitieren

APA

Jeng, L. B., Li, T. C., Wang, J., & Teng, C. F. (2023). Increased plasma levels of monocyte chemoattractant protein‐1 in patients with hepatitis B virus pre‐S2 gene deletion mutation predict a higher risk of hepatocellular carcinoma recurrence after curative surgical resection. Cancer. https://doi.org/10.1002/cncr.34815

Vancouver

Jeng LB, Li TC, Wang J, Teng CF. Increased plasma levels of monocyte chemoattractant protein‐1 in patients with hepatitis B virus pre‐S2 gene deletion mutation predict a higher risk of hepatocellular carcinoma recurrence after curative surgical resection. Cancer. 2023. doi:10.1002/cncr.34815

BibTeX
@article{Jeng2023,
  author = {Jeng, Long-Bin and Li, Tsai-Chung and Wang, John and Teng, Chiao-Fang},
  title = {Increased plasma levels of monocyte chemoattractant protein‐1 in patients with hepatitis B virus pre‐S2 gene deletion mutation predict a higher risk of hepatocellular carcinoma recurrence after curative surgical resection},
  journal = {Cancer},
  year = {2023},
  doi = {10.1002/cncr.34815}
}
Kostenlos starten →